
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
Qing‐Rong Liu, Chun‐Hung Pan, Akitoyo Hishimoto, et al.
Genes Brain & Behavior (2009) Vol. 8, Iss. 5, pp. 519-530
Open Access | Times Cited: 233
Qing‐Rong Liu, Chun‐Hung Pan, Akitoyo Hishimoto, et al.
Genes Brain & Behavior (2009) Vol. 8, Iss. 5, pp. 519-530
Open Access | Times Cited: 233
Showing 1-25 of 233 citing articles:
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou, Ujendra Kumar
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 833-833
Open Access | Times Cited: 1108
Shenglong Zou, Ujendra Kumar
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 833-833
Open Access | Times Cited: 1108
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood, Ken Mackie
British Journal of Pharmacology (2010) Vol. 160, Iss. 3, pp. 467-479
Open Access | Times Cited: 566
Brady K. Atwood, Ken Mackie
British Journal of Pharmacology (2010) Vol. 160, Iss. 3, pp. 467-479
Open Access | Times Cited: 566
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte, Marie-Renée Blanchet, Michel Laviolette, et al.
Cellular and Molecular Life Sciences (2016) Vol. 73, Iss. 23, pp. 4449-4470
Open Access | Times Cited: 483
Caroline Turcotte, Marie-Renée Blanchet, Michel Laviolette, et al.
Cellular and Molecular Life Sciences (2016) Vol. 73, Iss. 23, pp. 4449-4470
Open Access | Times Cited: 483
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng‐Xiong Xi, Xiao‐Qing Peng, Xia Li, et al.
Nature Neuroscience (2011) Vol. 14, Iss. 9, pp. 1160-1166
Open Access | Times Cited: 379
Zheng‐Xiong Xi, Xiao‐Qing Peng, Xia Li, et al.
Nature Neuroscience (2011) Vol. 14, Iss. 9, pp. 1160-1166
Open Access | Times Cited: 379
Cannabinoid CB 2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai‐Ying Zhang, Ming Gao, Qing‐Rong Liu, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 46
Open Access | Times Cited: 308
Hai‐Ying Zhang, Ming Gao, Qing‐Rong Liu, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 46
Open Access | Times Cited: 308
CB 1 and CB 2 Receptor Pharmacology
Allyn C. Howlett, Mary E. Abood
Advances in pharmacology (2017), pp. 169-206
Open Access | Times Cited: 294
Allyn C. Howlett, Mary E. Abood
Advances in pharmacology (2017), pp. 169-206
Open Access | Times Cited: 294
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel, Alexander Stumpf, Hai‐Ying Zhang, et al.
Neuron (2016) Vol. 90, Iss. 4, pp. 795-809
Open Access | Times Cited: 278
A. Vanessa Stempel, Alexander Stumpf, Hai‐Ying Zhang, et al.
Neuron (2016) Vol. 90, Iss. 4, pp. 795-809
Open Access | Times Cited: 278
CB2Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Amey Dhopeshwarkar, Ken Mackie
Molecular Pharmacology (2014) Vol. 86, Iss. 4, pp. 430-437
Open Access | Times Cited: 246
Amey Dhopeshwarkar, Ken Mackie
Molecular Pharmacology (2014) Vol. 86, Iss. 4, pp. 430-437
Open Access | Times Cited: 246
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
Slava Rom, Yuri Persidsky
Journal of Neuroimmune Pharmacology (2013) Vol. 8, Iss. 3, pp. 608-620
Open Access | Times Cited: 226
Slava Rom, Yuri Persidsky
Journal of Neuroimmune Pharmacology (2013) Vol. 8, Iss. 3, pp. 608-620
Open Access | Times Cited: 226
Brain cannabinoid receptor 2: expression, function and modulation
De‐Jie Chen, Ming Gao, Fenfei Gao, et al.
Acta Pharmacologica Sinica (2017) Vol. 38, Iss. 3, pp. 312-316
Open Access | Times Cited: 186
De‐Jie Chen, Ming Gao, Fenfei Gao, et al.
Acta Pharmacologica Sinica (2017) Vol. 38, Iss. 3, pp. 312-316
Open Access | Times Cited: 186
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 171
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 171
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Chloe J. Jordan, Zheng‐Xiong Xi
Neuroscience & Biobehavioral Reviews (2019) Vol. 98, pp. 208-220
Open Access | Times Cited: 165
Chloe J. Jordan, Zheng‐Xiong Xi
Neuroscience & Biobehavioral Reviews (2019) Vol. 98, pp. 208-220
Open Access | Times Cited: 165
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
Lihi Bar‐Lev Schleider, Raphael Mechoulam, Naama Saban, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Lihi Bar‐Lev Schleider, Raphael Mechoulam, Naama Saban, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier, Giulio G. Muccioli, Emmanuel Hermans, et al.
Biochemical Pharmacology (2010) Vol. 80, Iss. 1, pp. 1-12
Closed Access | Times Cited: 181
Barbara Bosier, Giulio G. Muccioli, Emmanuel Hermans, et al.
Biochemical Pharmacology (2010) Vol. 80, Iss. 1, pp. 1-12
Closed Access | Times Cited: 181
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
Emmanuel S. Onaivi, Hiroki Ishiguro, Shanzhi Gu, et al.
Journal of Psychopharmacology (2011) Vol. 26, Iss. 1, pp. 92-103
Open Access | Times Cited: 174
Emmanuel S. Onaivi, Hiroki Ishiguro, Shanzhi Gu, et al.
Journal of Psychopharmacology (2011) Vol. 26, Iss. 1, pp. 92-103
Open Access | Times Cited: 174
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
Femke S. den Boon, Pascal Chameau, Qiluan Schaafsma-Zhao, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 9, pp. 3534-3539
Open Access | Times Cited: 174
Femke S. den Boon, Pascal Chameau, Qiluan Schaafsma-Zhao, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 9, pp. 3534-3539
Open Access | Times Cited: 174
The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic Implications
Lydia Miller, Lakshmi A. Devi
Pharmacological Reviews (2011) Vol. 63, Iss. 3, pp. 461-470
Open Access | Times Cited: 164
Lydia Miller, Lakshmi A. Devi
Pharmacological Reviews (2011) Vol. 63, Iss. 3, pp. 461-470
Open Access | Times Cited: 164
Cannabinoid receptors: nomenclature and pharmacological principles
Linda Console‐Bram, Jahan P. Marcu, Mary E. Abood
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 38, Iss. 1, pp. 4-15
Open Access | Times Cited: 159
Linda Console‐Bram, Jahan P. Marcu, Mary E. Abood
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 38, Iss. 1, pp. 4-15
Open Access | Times Cited: 159
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment
Sasidhar Murikinati, Eric Jüttler, Timo Keinert, et al.
The FASEB Journal (2009) Vol. 24, Iss. 3, pp. 788-798
Closed Access | Times Cited: 155
Sasidhar Murikinati, Eric Jüttler, Timo Keinert, et al.
The FASEB Journal (2009) Vol. 24, Iss. 3, pp. 788-798
Closed Access | Times Cited: 155
Endocannabinoid modulation of dopamine neurotransmission
Dan P. Covey, Yolanda Mateo, David Sulzer, et al.
Neuropharmacology (2017) Vol. 124, pp. 52-61
Open Access | Times Cited: 153
Dan P. Covey, Yolanda Mateo, David Sulzer, et al.
Neuropharmacology (2017) Vol. 124, pp. 52-61
Open Access | Times Cited: 153
Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
In Young Choi, Chung Ju, Angela M. A. Anthony Jalin, et al.
American Journal Of Pathology (2013) Vol. 182, Iss. 3, pp. 928-939
Open Access | Times Cited: 144
In Young Choi, Chung Ju, Angela M. A. Anthony Jalin, et al.
American Journal Of Pathology (2013) Vol. 182, Iss. 3, pp. 928-939
Open Access | Times Cited: 144
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
Hai‐Ying Zhang, Ming Gao, Hui Shen, et al.
Addiction Biology (2016) Vol. 22, Iss. 3, pp. 752-765
Open Access | Times Cited: 135
Hai‐Ying Zhang, Ming Gao, Hui Shen, et al.
Addiction Biology (2016) Vol. 22, Iss. 3, pp. 752-765
Open Access | Times Cited: 135
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
Qing‐Rong Liu, Ana Canseco-Alba, Hai‐Ying Zhang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 134
Qing‐Rong Liu, Ana Canseco-Alba, Hai‐Ying Zhang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 134
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
Yong Li, J. Kim
Neuroscience (2015) Vol. 311, pp. 253-267
Open Access | Times Cited: 131
Yong Li, J. Kim
Neuroscience (2015) Vol. 311, pp. 253-267
Open Access | Times Cited: 131